Last Updated: 2026

GreenLight Biosciences

Summary

Summary

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

History

GreenLight Biosciences was founded in 2016 by Didier Bouayer as a spin-off from Synthorx Inc., a biopharmaceutical company. The company specializes in the development of novel microbial strains that use light-activated gene expression for synthetic biology research and platform microorganisms for biobased products.

Mission

GreenLight Biosciences is committed to creating novel biological solutions that improve the way science is done.

Vision

We aspire to be the top synthetic biology company and the global leader in light-controlled expression solutions.

References

https://in.investing.com/equities/environmental-impact

https://finance.yahoo.com/quote/GRNA/profile?p=GRNA

https://www.crunchbase.com/organization/greenlight-biosciences

https://companiesmarketcap.com/

https://greenlightbiosciences.com

Leadership team

Dr. Andrey Juan Zarur Ph.D. (Co-Founder, Pres, CEO & Director)